Investor Presentation
Filed with ASX · · 17 pages · English
MELBOURNE — Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer is pleased to share the updated investor presentation. Chief Executive Officer Robert (Bob) Proulx is conducting an investor roadshow in Sydney, Melbourne and Perth from Monday 9 - Friday 13 September, 2019. -ENDS About Imagion Biosystems Imagion Bios
Imagion Biosystems Ltd. on 6ix
In the deck
Earlier from Imagion Biosystems
- Appendix 4D and Half Year Report
- Imagion Biosystems receives A$2 million in R&D tax incentive
- FDA Breakthrough Device Designation
- Imagion Biosystems successfully completes toxicology study
- Imagion Biosystems receives R&D Advanced Overseas Finding
Later from Imagion Biosystems
- Pro-Rata Renounceable Rights Issue - Amended Timetable
- Completion of Renounceable Rights Issue
- Response to ASX price query
- Business Update - Manufacturing commences
- Appendix 4E and 2019 Full Year Results
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems